Home Blog Page 88

GoDaddy Canada features local small business Arioum Chocolats to inspire Quebec entrepreneurs to get their businesses online

0

 

With Semaine de la PME upcoming between October 17 to 23, GoDaddy is proud to showcase how easy and affordable it is for business owners to reach their goals online.

Established in 2017, Arioum Chocolats is a unique artisanal chocolate factory where Montrealers can enjoy assorted fine chocolates, bars, coated confits, spreads and more. A GoDaddy client since 2020, co-founders Noémie Roy Lambert and Ariel Barrios Humaran came together to combine their passion for confectionery and art.

Over the years, Arioum Chocolats has evolved from an artisanal chocolate factory to a café and boutique offering fine chocolates, gourmet drinks and delicacies. Like many small business owners, Arioum Chocolats adapted its business throughout the year, and introduced the Arioum experience at home, thanks to GoDaddy Online Store. Since creating their online store, Arioum Chocolats has seen a steady lift in sales with new ecommerce integrations.

“Arioum Chocolats is a true passion project, combining our love for the arts and confectionery into a colourful gathering place for Montrealers,” said Noémie Roy Lambert, co-founder of Arioum Chocolats. “Thanks to GoDaddy, we could continue investing in our passion, and creating a website helped our business grow during the past year. With GoDaddy Website Builder and Online Store, we can seamlessly manage our ecommerce inventory, communicate with customers via email and social media, and provide the same delightful Arioum experience at home.”

“GoDaddy is proud to partner with small business owners like Arioum Chocolats to encourage Quebec entrepreneurs to get their business online,” said Anne De Aragon, VP and Country Manager, GoDaddy Canada. “For small businesses, like Arioum Chocolats, who had to close their physical storefronts during the global pandemic, GoDaddy provides easy and affordable ecommerce solutions to help Canadian entrepreneurs  grow and stay engaged with their customers, by creating and managing an online presence for their business.”

With GoDaddy, creating a beautiful online store and website is easy. GoDaddy’s suite of products and services, including its Online Store Builder tool, helps Quebec entrepreneurs and small business owners reach their goals online. GoDaddy Online Store Builder offers a large selection of modern templates that suit unique business needs and includes powerful selling tools as well as built-in marketing tools to help businesses grow, making it even easier for entrepreneurs to create an ecommerce solution for their business. Quebec entrepreneurs can now also schedule, publish and monitor their company’s social media from the Website Builder dashboard, enabling entrepreneurs to easily create and manage all their social media channels from one place.

METRO Inc. Amends its Share Buyback Program Allowing for an Additional 1.5 Million Shares to be Repurchased

0

 

This amendment allows the Corporation to repurchase in the normal course of business an additional 1,500,000 of its Common Shares, bringing the total number of its Common Shares that can be repurchased under the program to 8,500,000, representing approximately 3.4% of its issued and outstanding shares on November 11, 2020. Since the beginning of its current normal course issuer bid program, the Corporation repurchased 7,000,000 Common Shares at a weighted average price of $57.68 per share for a total of $403,735,402. Repurchases were made through the facilities of the Toronto Stock Exchange at market price, in accordance with its policies and regulations, and through the facilities of alternative trading systems.
When it renewed its normal course issuer bid program, the Corporation was authorized to repurchase, in the normal course of business, between November 25, 2020, and November 24, 2021, up to 7,000,000 of its Common Shares representing approximately 2.8% of its issued and outstanding shares on November 11, 2020. On November 11, 2020, there were 250,195,026 issued and outstanding shares of which 207,099,132 were part of the outstanding public float of the Corporation. On November 11, 2020, the average daily trading volume of the Corporation’s Common Shares over the last six (6) completed months was 539,248 shares. No other terms of the normal course issuer bid program have changed.

The Corporation’s amended normal course issuer bid program came into effect on October 4 and will continue through November 24, 2021. Repurchases will continue to be made through the facilities of the Toronto Stock Exchange at market price, in accordance with its policies and regulations, or through the facilities of alternative trading systems as well as by other means as may be permitted by a securities regulatory authority, including by private agreements.

Hyperhomocysteinemia and low vitamin B12 are associated with the risk of early pregnancy loss

0

 

One-carbon metabolism is crucial for the maintenance of healthy pregnancy and alterations in this pathway have been associated with various pregnancy-related complications. Therefore, the present study was conducted to test the hypothesis that altered folic acid, vitamin B12 and homocysteine levels are associated with the risk of early pregnancy loss (EPL). Plasma folic acid, vitamin B12 and homocysteine levels were analyzed in 83 females with EPL and 70 healthy pregnant females in their first trimester.

Further, meta-analyses of folic acid, vitamin B12 and homocysteine were also performed involving various eligible studies. Results from the case-control study and meta-analysis showed that folic acid deficiency is not associated with the risk of EPL. On the other hand, low vitamin B12 and hyperhomocysteinemia were individually found to be significant risk factors for EPL in the present study.

Vitamin B12 deficiency in combination with hyperhomocysteinemia was a more serious risk factor for EPL (Odds Ratio = 4.98, P = 0.002). Therefore, vitamin B12 deficiency and elevated homocysteine levels are independent risk factors for EPL, and are of higher risk when combined. The assessment of vitamin B12 and homocysteine levels may serve as a good screening marker for EPL risk.

Bayer expands organic seed offerings

0

 

New certified production of seeds intended at helping boost access to healthier food.
The focus is on vegetables fitting the glass and greenhouse market such as tomatoes, sweet peppers and cucumbers. The new umbrella name is Vegetables by Bayer.

The decision to expand the company’s portfolio came in direct response to increased consumer interest for high-quality, organic food.

According to the International Federation of Organic Agriculture Movements (IFOAM), demand for certified organic products continues to grow. It estimates that today’s global organic food market is worth more than €106bn.

While the 2020 global market for organic food seeds, is valued at US$355M.

That number is foreseen to climb to US$480M by 2025, and this presents a valuable opportunity for Bayer‘s customers to grow their business as well as improve access to organic fruits and vegetables.

“We serve growers all over the world and believe that they should have the freedom to choose the tools or the practices that best suit the needs of their farms and the needs of their customers,” said Inci Dannenberg, president of Global Vegetable Seeds at Bayer.

Source: fruitnet

COVID-19 Stay-At-Home Impact on Health Behaviors

0

 

Confinement orders in response to the COVID-19 pandemic have driven sudden changes in daily routines. The study assessed lifestyle changes across different BMI classifications in response to the global pandemic.

The online survey targeting adults was distributed in April 2020 and collected information on dietary behaviours, physical activity, and mental health. All questions were presented as “before” and “since” the COVID-19 pandemic.

In total, 7,753 participants were included; 32.2% of the sample were individuals with normal weight, 32.1% had overweight, and 34.0% had obesity. During the pandemic, overall scores for healthy eating increased (P < 0.001), owing to less eating out and increased cooking (P < 0.001). Sedentary leisure behaviours increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001). Anxiety scores increased 8.78 ± 0.21 during the pandemic, and the magnitude of increase was significantly greater in people with obesity (P ≤ 0.01). Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.

The pandemic has produced significant health outcomes, well beyond the virus itself. Government mandates together with the fear of contracting the infection have significantly impacted lifestyle behaviours alongside declines in mental health. These deleterious impacts have disproportionally affected individuals with obesity.

Source: PMC

The First IRB-Approved Research Study

0

 

The First IRB-Approved Research Study on Entheogens & Psychedelic Experiences

– Resurgent is recruiting 100 participants to take part in the anonymous online survey –

– The research from the study will help to better inform the design of future research and therapies –

– Study is the first of its kind to receive approval from an independent Institutional Review Board (“IRB”) –

Goodness Growth Holdings, Inc., a physician-led, science-focused cannabis company and IP incubator, today announced that its subsidiary, Resurgent Biosciences, Inc. (“Resurgent”), is actively recruiting 100 participants to take part in an anonymous online survey to research the varying effects of entheogen and psychedelic experiences for therapeutic, religious, or spiritual purposes. The research will help inform Resurgent on future developments including research and wellness applications designed to help promote more positive, long-lasting outcomes from psychedelic-based therapies.
Existing research into the therapeutic use of psychedelics has focused heavily on synthetic substances, such as LSD, Ketamine, and MDMA, performed in controlled clinical settings. The survey being conducted by Resurgent, which has received approval from an independent Institutional Review Board (“IRB”) registered with the Office for Human Research Protections (“OHRP”), will instead focus on the naturalistic use of entheogens and other substances typically used in specific cultural and spiritual contexts for healing.

“Entheogens” refers to traditional substances, more commonly referred to as psychedelics, of fully natural origin and ingested to impact one’s consciousness for therapeutic, religious, or spiritual purposes. This is an innovative, first-of-its-kind survey delving into some key questions surrounding entheogen usage.

“Lab-based research will always be an essential aspect of our research and development process. However, to create more effective psychedelic-based therapies and services, we believe it is equally important to thoroughly explore the tremendous wealth of experience and wisdom that already exists and is active today based on centuries of both spiritual and therapeutic practices,” said Chief Medical Officer Stephen Dahmer, MD. “Learning from and respecting the rich history of psychedelic traditional practices as well as the extensive existing therapeutic use is an important first step to support a path for future therapies in the United States that afford long term safety and efficacy.”

To conduct this research, Resurgent will be performing an observational pilot survey, collecting self-reported, anonymous data from 100 adults who self-report having participated in entheogen therapy centers and retreats during the last five years on topics including their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research.

By collecting information from psychedelic-related ceremonies and retreats across the world, and particularly in South America, Resurgent aims to gain a greater understanding of these experiences and their impact on participants to develop better approaches for psychedelic-focused therapy and counselling.

“As a science-focused company, research remains the first and most important step in the development of new therapeutic approaches and supportive solutions related to psychedelics,” said Chairman and Chief Executive Officer, Kyle Kingsley, M.D. “As we work to further our understanding and acceptance of psychedelic-based therapies as beneficial, an IRB-approved research study will enable us to gather meaningful data to refine and focus our approach to the development of products related to psychedelics therapy.”

The research study is being conducted through a partnership with Flor da Jurema, a temple community in Brazil, where visitors can practice traditional forms of plant-based medicines and take part in spiritual experiences around the globe.

Amazon hiring more than 15,000 employees across Canada; increasing pay to $21.65

0

 

Amazon Canada today announced its commitment to hiring 15,000 full-time and part-time employees across Canada and increasing employees’ wages. Frontline employees will receive $17 per hour to $21.65 per hour with comprehensive benefits starting on day one, including access to health, dental and vision benefits, training and education programs, like the Career Choice program, and health and well-being initiatives such as My Wellbeing and family support plans.
 
“We take our responsibility as an employer seriously,” said Sumegha Kumar, Director of Canadian Customer Fulfillment Operations for Amazon Canada. “Amazon Canada employs over 25,000 Canadians, and we’re proud to create 15,000 more great jobs at a time when they’re needed in Canada, with increased pay for our amazing employees across our fulfillment, transportation and logistics networks — from Victoria to Dartmouth.”

Amazon Canada will hire 15,000 full-and part-time employees throughout the fall. Full-and part-time employees will also receive an additional $1.60 – $2.20 per hour, starting immediately, regardless of their tenure with the company.

Health and Benefits

At Amazon, every full-time employee, regardless of their position, level or tenure, has access to the same benefits. Some of those benefits include:

• Wages from $17 per hour to $21.65 per hour, with a $100 bonus for new and current employees who show proof of vaccination

• Comprehensive health benefits starting on day one with no waiting period
• RRSP matching
• Stock units
• Kids & Company special packages including a guaranteed spot at Kids & Company Child Care locations within six months of registration, a 10 percent discount off monthly in-center tuition, waived registration fees, backup care options and access to virtual workshops and events
• Employee and Family Assistance Plan provided by LifeWorks and available 24/7 to help Amazon employees and their family members feel supported, by phone, online, and in-person
• Access to up-skilling training programs that meet employees where they are, through Amazon’s commitment to invest $75M to skills-train 100,000 Amazonians by 2025
Additional paid parental leave benefits for eligible employees
• All eligible full-time employees have access to Amazon Career Choice, an innovative program uniquely designed to help upskill people who are interested in pursuing a future in a high-demand field by covering up to 95 percent of tuition fees.

“As a mother of six, Amazon’s flexible work schedules and advancement opportunities have helped me grow both at home and at work,” said Patrice Thompson, Processing Assistant at Amazon Canada. “I enrolled in the Career Choice program to further my education and today I can proudly say that I am a graduate of the Transportation and Logistics program from Sheridan College.”

New Study: Consumers Hold Retailers Responsible for Quality and Safety of Supplements, Personal Care Products and OTC Drugs

0

 

97% of consumers say it’s important for retailers to visit and inspect manufacturing facilities that produce dietary supplements, personal care products and OTC drugs.
Busy consumers with no time for in-depth product research are increasingly relying on retailers to screen out potentially unsafe and low-quality products, according to a new study from the global public health organization NSF International. The study finds 97% of American consumers believe it is important for retailers to visit and inspect manufacturing facilities that produce dietary supplements, personal care products and over-the-counter (OTC) drugs. Nearly 85% of survey respondents said they expect retailers to test supplements and other health and wellness products for safety.
Who is responsible?
Americans hold retailers responsible for the supplements and personal care products they sell.
“We’re seeing a trend across categories in the health and wellness sector – consumers increasingly want retailers to stand behind the products they sell,” said David Trosin, Managing Director of Health Sciences Certification at NSF International. “According to this research, consumers not only expect retailers to test products for safety, but they also want them to inspect manufacturing facilities for compliance with current good manufacturing practices.”

The online survey conducted in July 2021 on behalf of NSF International polled a representative sample of 1,000 Americans about their attitudes and behaviours related to dietary supplements, personal care products and OTC drugs. The margin of error for the study is +/-3.1% at a 95% confidence level.

Under U.S. federal regulations, manufacturers of dietary supplements and OTC drugs are required to comply with current good manufacturing practices (GMPs), but they are not required to provide proof of GMP compliance before shipping products. Recently, however, several major retailers and online shopping platforms have begun requiring brands and manufacturers to provide proof of GMP compliance and other quality assurance requirements. The new study suggests Americans want retailers to go beyond what’s required by law and conduct their own due diligence audits of manufacturing facilities.

“Failure to comply with GMPs can lead to a host of quality and safety issues. You can get cross-contamination of products, mislabeled products, inaccurate formulations and generally unhygienic conditions,” Trosin said. “Everyone in the industry understands the importance of good manufacturing practices and now it’s clear consumers are concerned about this too.”  

According to the survey, 95% of consumers have concerns about the quality and safety of dietary supplements, personal care products and OTC drugs. When asked what would make them trust these products more, 62% said “independent certification from a health and safety organization” and 61% said, “made in a facility that has been inspected for good manufacturing practices.” About 44% said “lab testing by the retailer” would help build their trust in supplements and personal care products. Only 14% said “advertising on TV” helps build their trust in products. “Social media comments” and “celebrity endorsements” were identified as building trust by just 17% of consumers.

Other highlights from the survey include:

• While consumers are concerned about product safety and quality, only 48% said they research dietary supplement product claims themselves and just 39% said they research personal care products and OTC product claims.

• Almost half of Americans (47%) are more likely to research a Hollywood movie than the claims on supplements and other health and wellness products.
• 17% of consumers said they are more likely to read the Facebook terms and conditions than the ingredient labels of supplements, personal care products and OTCs
• 56% of consumers said the COVID-19 pandemic made them more concerned about the safety of supplements, personal care products and OTC drugs
While 85% of consumers want retailers to test the health and wellness products they sell, only 32% think retailers actually do this.
• 62% of consumers believe national chain stores/pharmacies are “most likely to sell the highest-quality” health and wellness products. Just 28% said online sellers and 17% said fitness centers are “most likely to sell the highest-quality” products.
According to the survey, the consumers most likely to demand laboratory testing of supplements, personal care products and OTCs are consumers with children, consumers in urban areas, consumers 23 to 35 years old, and men making over $90,000 per year.

The survey data points to the increasing demand for independent product testing and GMP auditing. “We envision a future when most major retailers will require brands to show proof of product quality in some form or another, whether through independent assurance of GMP compliance, independent laboratory testing of products or both,” Trosin said.

The Edible Insects Trend

0

 

By 2023, The market for edible insects is expected to reach a value of $1.2 billion.
Insects have already been part of the North American food culture for some time and famously Houston, TX takes the crown of the edible insect capital. It is very common to find in restaurants dishes such as ‘pan sautéed grasshoppers, guacamole, tortillas and a side of chipotle-tomatillo salsa’.

Let’s not kid ourselves, edible insects are unlikely to become mainstream, however, the opportunities are clearly there. It will surely be a niche profit-based trend. Since many experts predict that humans will need to consume insects to sustain population levels, the opportunity might be in the very near future.

A UN report claims: “It is widely accepted that by 2050 the world will host 9 billion people. To accommodate this number, current food production will need to almost double. The land is scarce and expanding the area devoted to farming is rarely a viable or sustainable option. Oceans are overfished and climate change and related water shortages could have profound implications for food production. To meet the food and nutrition challenges of today – there are nearly 1 billion chronically hungry people worldwide – and tomorrow, what we eat and how we produce it needs to be re-evaluated.”

Biomanufacturing partnership boosts Canada’s life-saving treatment and vaccine capacity

0

 

As Canada seeks to rebuild its biomanufacturing sector and support made-in-Canada solutions to global health challenges, The Ottawa Hospital, the University of Alberta and BioCanRx have collaborated to create Canada’s first full-service, end-to-end biomanufacturing solution for academic and industrial clients.

The three organizations have signed a memorandum of understanding to enhance collaboration between:

• The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC), which has a 15-year track record of biomanufacturing and is home to Canada’s only hands-on biomanufacturing training program;
• Alberta Cell Therapy Manufacturing (ACTM), which has some of the most advanced biomanufacturing facilities in Canada;
• BioCanRx, a Canada-wide research network focused on developing and translating life-saving biotherapies and immunotherapies for cancer.

The partners are already collaborating to manufacture many therapies and vaccines, including:

• Potentially curative gene therapy for lipoprotein lipase deficiency, an inherited disorder that is more common in Québec;
• Mesenchymal stem / stromal cells for septic shock, a deadly condition that occurs when the immune system overreacts to an infection;
• COVID-19 vaccines, in partnership with Entos Pharmaceuticals.

“Canada has some of the best scientific minds in the world working to develop new therapies and vaccines, but they have been limited by our lack of domestic biomanufacturing capacity,” said Dr. Duncan Stewart, Executive Vice-President of Research at The Ottawa Hospital and a professor at the University of Ottawa. “This new partnership, which combines areas of strength across the country, will greatly enhance Canada’s ability to produce life-saving medical treatments and vaccines.”

“For Canada to play a key role in new breakthrough therapies and vaccines, we must invest in multiple facilities across the country, and foster collaboration,” said Dr. Greg Korbutt, Scientific Director of ACTM and Professor of Surgery at the University of Alberta. “This agreement sets the stage for that, a Canadian biomanufacturing ecosystem.”

“This partnership will not only scale up our domestic biomanufacturing capacity but include hands-on GMP training to meet the astounding demand for biomanufacturing personnel,” said Dr. Stéphanie Michaud, President and CEO of BioCanRx. “More importantly, it serves to support our ‘made-in-Canada approach focused on expanding access to clinical trials for potentially life-saving cancer treatments, right here, in Canada.”

“Canada has deep biopharma research experience, so it’s great to see expansion in the biomanufacturing sector. Hopefully, Canada continues to invest in initiatives such as this,” said Entos CEO John Lewis. “Accessing the facilities and expertise at ACTM and The Ottawa Hospital has significantly helped propel our COVID-19 vaccine candidate into clinical trials.”